N/A
21 Years
N/A
21 Years
N/A
Open (Enrolling)
Both
Advanced Solid Tumors
Both
Advanced Solid Tumors
Trial Information
Inclusion Criteria:
Advanced Solid Tumor
Exclusion Criteria:
Non advanced solid tumor
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Inhibition of STAT3 phosphorylation in peripheral mononuclear blood cells (PBMCs)pharmacodynamic effect of OPB-51602 in surrogate tissue.
Outcome Description:
Analysis
Outcome Time Frame:
1 year
Safety Issue:
No
Authority:
Singapore: Domain Specific Review Boards
Study ID:
PG01/04/11
NCT ID:
NCT01867073
Start Date:
May 2011
Completion Date:
May 2015
Related Keywords:
- Advanced Solid Tumors
Name | Location |
|---|
